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ABSTRACT 
 
An electrochemical sensor based on graphene oxide decorated with gold nanoparticles 
has been prepared for the simultaneous quantification of uric acid (UA) and ascorbic 
acid (AA) in urine samples. The gold interdigitated microelectrodes array (Au-IDA) has 
been modified using graphene oxide doped with gold nanoparticles (AuNPs-GO/Au-
IDA), which was characterized by TEM, FE-SEM, XPS and cyclic voltammetry 
Excellent results were obtained for the separate quantification of UA and AA by 
chronoamperometry. The electrochemical sensor exhibits limits of detection (LODs) of 
1.4 M and 0.62 M for AA and UA, respectively, limits of quantification (LOQs) of 
4.6 M (AA) and 2.0 M (UA), and the working ranges obtained were between 4.6 M 
and 193 M for AA and between 2 M and 1.05 mM for UA. The repeatability was 
studied at 20 M providing coefficients of variation of 16 % for AA and 13 % for UA. 
Moreover UA does not interfere in the measurement of AA and viceversa (provided that 
the concentration of UA is equal to or higher than 450 M in the latter case). For lower 
concentrations of UA, an easy and fast strategy to quantify both analytes is presented. 
The good electrocatalytic activity achieved with this material makes it useful for the 
quantification of AA and UA in biological fluids. Other analytes like glucose, dopamine 
and epinephrine have been investigated. The results allow us to conclude that they do 
not interfere in the quantification of AA and UA in PBS (0.25 M, pH 7.0). Human urine 
samples have been analyzed using the method proposed, contaning AA and UA 
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concentration levels of (0.588  0.002) mM and (1.43  0.02) mM, respectively, which 
are in the concentration range of these analytes in urine samples for healthy people. 
 
 
Keywords: electrochemical sensors; graphene oxide; gold nanoparticles; 
uric acid; ascorbic acid 
 
 
1. Introduction 
 
Uric acid (UA; 7,9-dihydro-1H-purine-2,6,8(3H)-trione) is a weak acid present in 
extracellular fluids as sodium urate. Since anomalous UA levels in biological fluids 
have been linked to several diseases, researchers have developed several methods to 
detect it. Some illnesses like gout, hypertension, and cardiovascular disease, have been 
related to UA serum concentrations over 420 M [1]. Other conditions like 
neurodegenerative diseases may be caused by UA concentrations lower than 120 M 
[2]. Thus, UA normal levels in serum are established between 120 and 420 M, with 
slight variations depending on the gender. Since recent studies have provided evidences 
that altered levels of UA in serum might have a role in the development of disease states 
[3], the manipulation of serum UA levels has been employed in the treatment of a 
variety of diseases [4]. Consequently, the development of a method to reliably quantify 
UA concentration in biological fluids has acquired increasing interest during the last 
decades. 
As UA can be oxidised at common electrodes in aqueous solution, electrochemical 
sensors have been widely used for UA detection due to their advantages such as short 
analysis times, simple experimental procedures, and economical instrumentation. 
However, the main disadvantage for the quantification of UA in biological fluids by 
electrochemical sensors is the presence of species whose oxidation takes place at 
potentials near the UA oxidation potential on most of the common electrodes. This 
occurs with the oxidation of ascorbic acid (AA), resulting in a poor selectivity towards 
UA [5]. 
Moreover, the determination of AA in biological fluids is also very interesting, since it 
is well-known that AA is related to some diseases, and that it cannot be synthetized by 
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humans and it should be incorporated via diet [6]. A normal range of AA concentrations 
in plasma has been set between 50 and 80 M [7,8]. An insufficient amount of AA 
causes symptoms of scurvy [9], but high concentrations results in gastric irritations [10]. 
Furthermore, AA has an important role in healthy cell development, normal tissue 
growth, and the healing of injuries, among other biochemical functions [11]. As a result, 
a huge effort has been done in order to detect and quantify both analytes separately and 
simultaneously in biological fluids, such as plasma or urine.  
Electrochemical sensors based on carbon materials are commonly used for their low 
cost, good chemical stability, good electron transfer kinetics, and biocompatibility. 
Specifically, graphene and its derivatives have been widely used in electrochemical 
sensors due to their physical and electrochemical properties [12]. At present, the use of 
graphene oxide (GO), the oxygenated derivative of graphene, is the most promising 
material for the preparation of colloidal suspensions due to oxygen-containing 
functional groups on its surface, which provide hydrophilicity [13], facilitating its 
dispersion in aqueous media, and conferring high tolerance towards chemical 
modification [14]. As a result of the easy processing and handling of GO and its 
electrochemical flexibility, most of the recent efforts in the electrochemical carbon-
based sensors have been based on this material. The advantages of GO allow the 
preparation of more concentrated dispersions, resulting in a shorter time for electrode 
modification. Moreover, the oxygen functional groups are amenable for bioconjugation 
toward the construction of biosensors, immunosensors and other devices [12]. The 
oxygen functional groups on GO can be reduced and regenerated electrochemically [15] 
with better electrical properties, high density of defects, and edge-like planes. Such 
combined properties enhance fast electron transfer, enabling its application in 
electrochemical sensing and biosensing. In order to increase its sensitivity and 
selectivity, GO usually is functionalised with other materials, such as nanoparticles or 
polymers [16–21]. At present, several of the recent studies have combined gold 
nanoparticles with graphene-based materials for electrochemical sensors and biosensors, 
trying to take advantage of the catalytic character and biocompatibility of gold. The 
presence of surface oxygen groups in GO increases the interaction between the metal 
catalyst and support [13]. 
The detection and quantification of UA and AA have been performed by differential 
pulse voltammetry (DPV) with an electrochemical sensor based on graphene oxide 
modified with gold nanoparticles, achieving limit of detection (LOD) of 20 M and 200 
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M, respectively [22]. However, the LOD obtained for AA should be improved due to 
the fact that levels of AA in plasma for healthy people are usually lower [7,8] and the 
detection of concentrations lower than 20 M is also interesting [8,23]. The 
simultaneous determination of AA and UA within other compounds has been evaluated 
using a sensor based on overoxidized polyimidazole and graphene oxide copolymer by 
cyclic voltammetry [24]. The proposed sensor exhibited a linear response range for AA 
between 75 µM and 2275 µM, and for UA between 3.6 µM and 249.6 µM. Several 
works have been reported for the electroanalytical determination of UA and AA in the 
presence of other compounds and most of them used a glassy carbon electrode as 
support of the modified-GO [17,18,20]. Benvidi et al. fabricated a reduced graphene 
oxide (RGO), gold nanoparticles and 2-(3,4-dihydroxyphenyl)benzothiazole-modified 
glassy carbon electrode for the simultaneous determination of levodopa, uric acid and 
folic acid [17]. Only a few publications may be found related with modified 
interdigitated arrays [21,25] or screen-printed electrodes [19], with a small size which 
makes the development of portable Lab-on-a-Chip devices feasible.  
The aim of the present work is the preparation by a one-step method of an electroactive 
material based on graphene oxide with gold nanoparticles with low loadings supported 
on gold interdigitated microelectrodes. Gold nanoparticles were synthesized following a 
method which allow not only fine nanoparticle size and distribution control but also 
avoid the use of additional reducing agents, improving the cost-efficiency of the 
synthetic process [26]. The modified electrodes have been assessed in the simultaneous 
detection and quantification of AA and UA in biological fluids, also improving the 
limits of detection hitherto achieved by using graphene oxide as support of metallic 
nanoparticles. To the best of our knowledge, this is the first time that an interdigitated 
electrode array is modified with Au-decorated graphene oxide sample, allowing the 
development of portable sensors for the simultaneous UA and AA determination. 
 
2. Experimental 
 
2.1. Reagents and equipment 
 
Uric acid (≥99%, crystalline) and L-Ascorbic acid (reagent grade, crystalline), 
dopamine hydrochloride, glucose and epinephrine standard chemicals, glutaraldehyde 
(50%) and poly(styrenesulfonate) (PSS) were provided by Sigma-Aldrich. Potassium 
dihydrogen phosphate (KH2PO4) and Potassium phosphate dibasic (K2HPO4) obtained 
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from Emsure® and Sigma-Aldrich respectively, were used to prepare buffer solution 
(PBS, 0.25 M, pH 7.0). Sulphuric acid (98%) was provided by AnalaRNormapur®. 
Ultrapure water was obtained by a treatment in Purelab Ultra Elga with a resistivity of 
18 MΩ·cm. Sodium hydroxide proanalysis (NaOH) was purchased from Merck. 
The reagents employed in the gold nanoparticles synthesis, (poly-n-vinylpyrrolidone 
(PVP), anhydrous ethylene glycol, sodium tetrachloroaurate dehydrate 
(NaAuCl4·2H2O), methanol and sodium hydroxide (NaOH; 99.99% purity) were 
purchased from Sigma-Aldrich. Isopore Membrane Filters (0.2 m GTTP) from 
Millipore were employed for cleaning and drying of the material synthesized and 
absolute ethanol was purchased from PROLABO. 
Transmission electron microscopic measurements (TEM) were carried out using a JEOL 
TEM, JEM-2010 model equipped with an Oxford X-ray detector (EDS), INCA Energy 
TEM 100 model, and GATAN acquisition camera. Scanning electron micrographs 
(SEM) were taken using an ORIUS SC600 model Field Emission Scanning Electron 
Microscope (FE-SEM) using a ZEISS microscope, Merlin VP Compact model, with an 
EDX Bruker, Quantax 400 model. 
X-ray photoelectron spectroscopy (XPS) was performed using a VG-Microtech 
Multilab 3000 spectrometer using non-monochromatised MgKα (1253.6 eV) radiation 
from a twin anode source operated at 300 W (20 mA, 15 kV). Photoelectrons were 
collected into a hemispherical analyser working in the constant energy mode at pass 
energy of 50 eV. The binding energy (BE) of the Cls peak at 286.4 eV was taken as 
internal standard. 
 
2.2. Preparation of graphene oxide decorated with gold nanoparticles 
 
2.2.1. Synthesis and purification of graphene oxide decorated with 
gold nanoparticles 
 
Graphene oxide was prepared following the Hummers method improved by Marcano et 
al. [27]. 
Gold nanoparticles were synthesized following a method based in the methodology 
described by Dominguez et al.[26] with several modifications which allow not only fine 
nanoparticle size and distribution control (as most chemical methods for the synthesis of 
metallic colloids, which represents a significant advantage over other methods) but also 
avoid the use of additional reducing agents, improving the cost-efficiency of the 
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synthetic process. In order to control the nanoparticle size and to obtain a good size 
distribution, the synthesis was performed in an inert atmosphere in a Schlenk system 
unless stated otherwise. 
In order to decorate the graphene oxide support with a 10% (w/w) of gold nanoparticles, 
the following method was applied. For solution 1, in a two-necked, round-bottom flask, 
0.075 g of graphene oxide and 0.120 g of poly-n-vynilpyrrolidone were added to 12 mL 
of anhydrous ethylene glycol. The mixture was maintained at 80ºC under stirring 
conditions for 1 h. For solution 2, in a two-necked, round-bottom flask, 0.022 g of gold 
precursor (NaAuCl4·2H2O) were dissolved in 5 mL of methanol under stirring at room 
temperature during 1 h. The resulting solution was of yellow color. 
After that, solution 1 was cooled at 0ºC with an ice bath and solution 2 was added to 
solution 1, keeping the stirring to ensure a good homogenization. The pH of the 
resulting solution was adjusted to 9-10 by adding 0.5 mL of a NaOH 1 M solution and 
the resulting solution was heated at 100 ºC under vigorous stirring for 2 h. After 2 hours 
the flask was removed from the bath and cooled to room temperature.  
The GO decorated with AuNPs was purified with a vacuum filtration system. The 
sample on the filter was cleaned with an excess of ethanol and the solid obtained was 
dried in a vacuum oven at 40ºC for 24 h. 
 
2.2.2. Graphene oxide decorated with gold nanoparticles dispersion 
 
Dispersions of 1 mg·mL-1 of graphene oxide (GO) and graphene oxide modified with 
gold nanoparticles (AuNPs-GO) were prepared in water. Both dispersions contained 1% 
PSS in order to achieve the dispersion of the carbon material. To obtain a proper 
dispersion, an ultrasound probe was applied for 10 min (QSonica, MODEL Q125, 
100W). In order to avoid localized heating during sonication, the vessels containing the 
sample suspensions were immersed in an ice bath. 
 
2.3. Preparation of Au-IDA modified electrodes 
 
First, cyclic voltammetry was performed in order to clean the gold (thin film of 150 nm) 
interdigitated microelectrodes array (Au-IDA1, Micrux). The size of the working 
electrode is 10 µm. Then, ten cycles between -1.5 V and 1.5 V versus the gold pseudo-
reference at 0.1 V s-1 in 0.05 M H2SO4 were applied.  
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Then the Au-IDA microelectrode was modified by casting the aqueous AuNPs-GO 
dispersion obtaining the AuNPs-GO/Au-IDA modified electrode. An Au-IDA modified 
electrode with GO was also prepared for electrochemical characterization. In both kinds 
of electrodes, the weight of the graphene oxide-based material deposited was 5 g. The 
method for the deposition was the dropwise addition of 0.5 µL of each dispersion and 
drying under an infrared lamp. Finally, 0.75 L of glutaraldehyde were added to ensure 
that the solid material remains on the surface of the Au-IDA electrode. The scheme 
shown in Figure 1 illustrates the preparation procedure for the sensor electrode. 
 
2.4.  Electrochemical methods 
 
All electrochemical measurements were carried out on a BIOLOGIC SP-300 
potentiostat. A three-electrode configuration was used, in which the electrode modified 
with graphene oxide-based material was the working electrode (WE), a reversible 
hydrogen electrode (RHE) was the reference electrode (RE) and a platinum wire was 
the counter electrode (CE). The electrochemical cell was completely deoxygenated 
during measurements by bubbling nitrogen. All potentials presented are referred to the 
RHE electrode. 
To identify the analytes, cyclic voltammetry was carried out in order to know at which 
potential the oxidation of UA and AA occurs. For that, a concentrated stock UA 
solution (100 mM) was prepared in PBS (0.25 M, pH 7.0) at a pH higher than 8.4 and 
then diluted ten times. A concentrated stock AA solution (135 mM) was also prepared. 
Three different aliquots from the stock solutions were added to the electrochemical cell 
to reach the desired concentration (CAA = 75, 175 and 275 M; CUA = 200, 400 and 600 
M). Afterwards, cyclic voltammetry was applied between 0.3 V and 1.3 V. 
Quantification of UA and AA was carried out by chronoamperometry. A total of 
fourteen aliquots of UA were added reaching concentrations between 0.62 M and 1 
mM. For AA, twenty-two AA additions were performed, in the concentration range 
between 1.4 M and 3 mM. Stirring was kept during the experiments to ensure a good 
homogenization. All measurements were carried out in PBS (0.25 M, pH 7.0) and by 
triplicate in order to determine analytical parameters. 
It is important to highlight that since the pH of the physiological fluids employed is 
higher than the pKa1 of these analytes, the quantification of ascorbate monoanion (HA
-) 
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[8] and urate (HU-) [28] has been determined. However, these analytes will be referred 
to as AA and UA throughout the manuscript, respectively. 
For real samples determination, filtered urine was diluted 20 times in PBS (0.25 M, pH 
7.0) and no other treatment was carried out.  
 
3. Results and Discussion  
 
3.1.  AuNPs-GO/Au-IDA electrodes characterization 
 
3.1.1. Electrochemical characterization 
 
The electrochemical behavior of GO/Au-IDA and AuNPs-GO/Au-IDA electrodes was 
studied by cyclic voltammetry in PBS (0.25 M, pH 7.0). Figure 2 depicts the 
voltammograms registered between 0.0 V and 1.8 V with a scan rate of 0.1 V s-1. 
Twelve cycles between 0.0 V and 1.8 V were performed and from cycle 8 the steady 
voltammograms were obtained.  
For GO/Au-IDA electrode (Figure 2, dashed line), the formation of the electrical double 
layer is manifested by the rectangular shape of the voltammogram between 0.5 V and 
1.8 V. For AuNPs-GO/Au-IDA electrode (solid line in Figure 2), the oxidation process 
of the gold surface at 1.5 V is observed during the positive scan and the reduction peak 
at 1.1 V related to the desorption of oxygen from the gold surface can be clearly seen. In 
addition, a high cathodic current can be seen due to the electrocatalytic effect of the 
AuNPs in the hydrogen reduction reaction on the gold surface. 
 
3.1.2. Structural characterization 
 
Figure 3 shows two representative TEM images for the GO and the AuNPs-GO 
dispersions. As it can be seen in Figure 3A, single layer structured GO flakes with a 
smooth surface were provided. The TEM micrograph of AuNPs-GO dispersion (Figure 
3B) shows a uniform distribution of the AuNPs on GO surface, with an average particle 
size between 4-9 nm, as shown in the histogram (Figure 3C). The presence of wrinkles 
in Figure 3A is an evidence of the conformational flexibility of GO, which is the reason 
why GO is locally folded in double or multiple layers [29].  
 
The surface morphology of the modified electrode (AuNPs-GO/Au-IDA) was 
characterized by FE-SEM. Figure 4 presents a material with several layers of graphene. 
The spots observed in Figure 4 correspond to the AuNPs. It can be observed that the 
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nanoparticles are homogeneously distributed on the electrode, and the entire Au-IDA 
electrode surface is covered. Figure 4 also shows the same sheet wrinkling, which 
indicates the presence of several layers of GO. 
XPS was used in order to determine the state of the main constituents of the dispersion 
(namely, Au, C, and O). The elemental contents of carbon, oxygen and gold were also 
quantified for both dispersions. Figure 5 shows the XPS spectra of gold for the AuNPs-
GO dispersion, in which a single peak appears for the Au 4f7/2 and Au 4f5/2 signals 
which may be assigned to zerovalent gold. The results for the pristine GO dispersion 
had a carbon and oxygen contents of, 80 wt% and 20 wt%, respectively. For the 
AuNPs-GO dispersion the XPS results showed a 1.9 wt% of gold, 81.3 wt% of carbon 
and 16.8 wt% of oxygen in the sample. Comparing the amount of oxygen in both 
dispersions a decrease in the amount of oxygen after gold nanoparticles were 
synthetized on GO (20 wt% for GO dispersion vs 16.8 wt% for AuNPs-GO dispersion) 
can be seen, which may be ascribed to the presence of the metallic particles. This 
observation is corroborated by the fact that the C1s XPS spectra for both samples 
(results not shown) were very similar, with negligible variations in the relative 
intensities of the peaks which may be ascribed to graphitic carbon (peak at 284.9 eV), 
phenol or ether-related groups (286.3 eV), quinone-related groups (287.5 eV), and 
carboxyl or ester-related groups (288.9 eV) [30].  
 
3.2. Electrochemical determination of AA and UA on AuNPs-GO/Au-
IDA electrodes. 
 
 
The electrochemical oxidation activity of AuNPs-GO/Au-IDA modified electrode 
towards UA and AA was investigated. Figure 6 shows the voltammograms obtained for 
three concentrations of AA (Figure 6A) and UA (Figure 6B). A peak around 0.7 V due 
to the oxidation of AA (Figure 6A) and a peak around 1.0 V related to the oxidation of 
UA (Figure 6B) can be observed. In order to minimize any possible interferences 
usually found in biological fluids, the oxidation potentials selected for AA  (0.75 V) and 
UA (1.0 V) detection by amperometric methods were the minimum possible without 
causing a substantial sensitivity decrease in the detection of either AA or UA, 
respectively. 
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Figure 7 exhibits the amperometric response of AuNPs-GO/Au-IDA electrode towards 
the several additions of AA and UA in PBS (0.25 M, pH 7.0). Figures 7A-B show the i-t 
curves obtained with the modified electrode towards AA additions at a fixed potential of 
0.75 V. The corresponding calibration curve obtained is shown in Figure 8A. As it can 
be observed in Figure 8A (inset), the analytical range studied seems to be characterized 
by two linear ranges, which means that the functional relationship is not linear at all. 
The reduction of the concentration range is one of the most widespread strategies to 
solve this [31]. To achieve this, a working response range between 4.6 M and 193 M 
is established, with a LOD and LOQ of 1.4 M and 4.6 M, respectively. The linear 
regression function is: iAA (nA) = (830  60) CAA (mM) + (7  5); with a correlation 
coefficient given by r = 0.996 (N = 10). 
In Figures 7C-D, the i-t curves obtained at 1.0 V for successive aliquots of UA can be 
observed, and the corresponding calibration curve is plotted in Figure 8B. A working 
response range was found for UA oxidation between 2 M and 1.05 mM. The LOD and 
LOQ obtained were 0.62 M and 2 M, respectively. The linear equation is next given 
by: iUA (nA) = (72816) CUA (mM) + (13 7); r = 0.999 (N = 12).  
 
All analytical figures of merit calculated for the quantification of AA and UA are 
summarized in Table 1. The LOD was determined empirically, measuring progressively 
more diluted concentrations of the analyte. The LOD was the lowest concentration 
whose signal could be clearly distinguished from the blank. Moreover, the LOQ was 
calculated as 3.3 times the LOD (LOQ = 3.3LOD) [32]. The coefficient of variation 
values (CV) were obtained for 3 replicates at 20 M concentration level of UA and AA. 
 
3.3. Simultaneous detection of AA and UA 
 
In order to study the simultaneous detection of AA and UA, cyclic voltammetry was 
performed in a solution containing the two analytes. Figure 9 shows the voltammograms 
obtained for the AA and UA interference study. Figure 9A displays the behavior of 
AuNPs-GO/Au-IDA electrode for a UA concentration of 600 M and successive 
aliquots from a stock solution of AA until reaching concentrations between 30 and 90 
M. The voltammograms obtained do not show differences after the additions of AA in 
this range of concentrations.   
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The results obtained for the addition of UA aliquots in a solution containing 275 M 
AA are presented in Figure 9B. As it is exhibited in the voltammetric curves, the current 
of the voltammetric peak owing to AA oxidation (E = 0.75 V) decreased after UA 
aliquots were added. Then, it seems that UA interferes in the voltammetric response of 
AA. Then, the amperometric responses for minimum and maximum levels of AA and 
UA were determined to have a broad knowledge about how each analyte interferes in 
the determination of the other. 
 
The interference study of UA and AA has been performed by chronoamperometry at 
0.75 V and 1.0 V, respectively and with concentrations higher than the normal values in 
serum. Figure 10 and Figure 11 display the i-t curves recorded for the interference 
study. Figure 10 evidences the effect of the addition of UA with a concentration 
between 120 M and 1.0 mM in the current at 0.75 V when the concentration of AA is 
30 M (Figure 10A) and 90 M (Figure 10B), respectively in the PBS solution. As it 
can be observed, additions of UA with a concentration within the established lineal 
range (120-1000 M), do not change the intensity of the AA oxidation current measured 
at 0.75 V.  Thus, the present method should be able to quantify AA with UA being 
present in the serum samples. 
 
 
On the other hand, Figure 11 shows the effect of the addition of AA with a 
concentration between 30 M and 90 M in the UA oxidation current at 1.0 V when the 
UA concentration is 120 M (Figure 11A) or 450 M (Figure 11B) in the solution. It 
can be observed for the lowest UA concentration established in serum (120 M, Figure 
11A) that additions of AA lead to an increase on the current measured at 1.0 V 
potential. That means that AA interferes in the quantification of low concentrations of 
UA. 
However, when the UA concentration is the highest allowed for healthy people (around 
450 M), Figure 11B depicts how the AA additions lead to a small increase in the 
measured current (21, 11 and 33 nA for the 1st, 2nd and 3rd aliquot, respectively). Taking 
into account that confidence limits for this concentration values are about  30 nA, this 
increase can be considered included in the experimental error of the measurements. As a 
result, this method is able to quantify UA in unhealthy people (UA concentration at 
least 450 M) in presence of AA up to a concentration of 60 M. 
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In order to apply the present method to healthy people, whose UA levels are lower than 
450 M, the following strategy may be applied: 1) calibration curve of AA at 0.75 V, 2) 
calibration curve of UA in the presence of the amount of AA in the real sample at 1.0 V 
potential. Preparation of calibration curve 2 requires knowing the concentration of AA 
in the sample beforehand. In order to avoid the preparation of a calibration curve (i-t 
curve at 1.0 V) after knowing the amount of AA present in the real sample, it becomes 
advisable to prepare several i-t curves with different AA concentrations between 10 M 
and150 M. Thus, the method can be applied in people with AA levels lower or higher 
than the fixed range levels. The sample, which contains a mixture of AA and UA will 
be subjected to chronoamperometry. First of all, the i-t curves at 0.75 V and 1.0 V 
potential of the sample will be recorded. The i-t curve at 0.75 V will provide a current 
intensity value (iAA,1), which is directly related to the concentration of AA (CAA)  by the 
linear function of calibrate curve 1. From the i-t curve at 1.0 V, a second current value 
(iT = iAA,2 + iUA) will be obtained, from which the amount of UA in the sample can be 
quantified by using the linear function of calibrate curve 2, which has been made with 
the amount of AA that was present in the real sample. 
 
3.4. Study of other interferences 
 
Other possible interferences, like glucose, dopamine (DP) and epinephrine (EP) were 
investigated by chronoamperometry at 0.75 V and 1.0 V in PBS (0.25 M, pH 7.0), to 
know if the presence of these analytes in physiological fluids are able to modify the 
signal belonging to the oxidation of AA and UA.  
In order to study the interference of these compounds, concentrations of glucose (5 
mM) [33], dopamine (1 M) [34], [35] and epinhefrine (0.5 M) were used, being these 
concentrations higher than the usually found in serum [36], [37]. Interferences at 0.75 V 
and 1.0 V were investigated in a 50 M AA solution and 420 M UA solution, 
respectively, being these concentrations usually found in serum, and the results obtained 
are displayed in Figure 12. 
 
As it can be observed in Figure 12 the addition of glucose, dopamine and epinephrine 
does not change the current intensity corresponding to the oxidation of AA at 0.75 V 
(Figure 12A) and UA at 1.0 V (Figure 12B). As a result of that, it can be concluded that 
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the method developed is able to quantify AA and UA, even in the presence of the 
analytes studied above. 
  
Finally, Table 2 shows a comparison of some analytical parameters obtained in this 
work, with others results previously reported. It can be observed that the proposed 
sensor is competitive, representing therefore a good and interesting alternative. 
Moreover, the LODs and LOQs achieved with the proposed sensor are greatly improved 
with respect to those shown in a recent publication about this topic [22], whose 
similarity lies in the same electrode material.  
 
3.5. Human urine samples 
 
A human urine sample from a healthy person was analyzed by the standard addition 
method due to matrix effects, which caused the displacement of the oxidation peaks 
related to AA and UA to more positive potentials (results not shown). Despite the fact 
that the possible interferences have been studied in PBS with proper results, urine is a 
complex matrix with several components like proteins that can block the active sites on 
the electrode. Filtered urine was diluted 20 times in PBS (0.25 M, pH 7.0) and no other 
treatment was carried out.  
For this reason the calibration curves for AA and UA were obtained by 
chronoamperometry at 0.95 V and 1.2 V, respectively, for the same concentrations of 
AA and UA studied in Figure 7. The concentration of AA determined was 0.588  
0.002 mM or 155.3  0.7 mg/24 h (based on a 1.5 L total urine volume in 24 hours 
[45]). The average AA value excreted by urine in 24 hours has been determined in 34 
mg. However, that value can be changeable, and for example, a high concentration of 
450 mg/24 h has been found after the ingestion of 700 mg of AA [46]. For that reason, 
the AA concentration found in the present work is not surprising. 
On the other hand, the urine sample had a concentration of 1.43  0.02 mM of UA or 
361  5 mg/24 h, values which are within the normal levels of UA (200-2000 mg/24 h 
[47] or 1.4 - 3.3 mM [48]).   
Inter-sensor reproducibility was studied using five electrodes prepared using the method 
described in section 2.3. The obtained results yielded coefficients of variation (CV) 
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values about 27% for AA and about 9% for UA determination which prove the 
reliability of the developed method (Figure 13). 
 
2. Conclusions 
 
An electrochemical method based on the modification of an array of gold interdigitated 
microelectrodes by graphene oxide decorated with gold nanoparticles (AuNPs-GO/Au-
IDA) has been developed for quantification of AA and UA in urine samples. In order to 
simulate physiological human fluids all investigations have been carried out in PBS 
(0.25 M, pH 7.0). The AuNPs-GO/Au-IDA modified electrode exhibits a working range 
of 4.6-193 M for AA and 2-1.05 mM for UA achieving LODs of 1.4 M and 0.62 M, 
respectively. These good values make the application of the method in serum samples, 
or other biological fluids possible, even when the AA and UA concentrations are lower 
than the normal values in serum.  
The simultaneous quantification of AA and UA has been investigated. No interference 
of UA in the AA measurements has been carried out successfully. On the other hand, 
AA does not interfere in the UA quantification for UA concentrations higher than 450 
M. For lower concentrations of UA, an easy and fast strategy to quantify both analytes 
was presented. The proposed sensor showed excellent antiinterference properties against 
glucose, dopamine and epinephrine and it has been favorably applied on the analysis of 
real urine samples. 
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Figure 1. Schematic illustration of the preparation procedure of the sensor described in 
this study: A) AuNPs-GO dispersion. B) Addition of 0.5 L of AuNPs-GO dispersion 
on Au-IDA electrode. C) Drying by IR lamp and D) Storage in PBS (0.25 M, pH 7.0) 
until its use. 
A B 
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Figure 2. Steady state voltammograms in PBS (0.25 M, pH 7.0), v scan = 0.1 V s
-1. 
Electrodes used: GO/Au-IDA (dashed line) and AuNPs-GO/Au-IDA (solid line). 
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Figure 3. TEM images of: A) GO dispersion; B) AuNPs-GO dispersion and C) 
histogram of gold nanoparticles size. 
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Figure  
Figure 4. FE-SEM image for AuNPs-GO/Au-IDA modified electrode. 
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Figure 5. Au 4f7/2 and Au 4f5/2 XPS spectra for AuNPs-GO dispersion. 
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Figure 6. Cyclic voltammograms for AuNPs-GO/Au-IDA electrode for: A) different 
AA concentrations: 0 M (black solid line), 75 M (green dashed), 175 M (blue 
dotted), and 275 M (pink dashed dotted); B) different UA concentrations: 0 M (black 
solid line), 200 M (green dashed), 400 M (blue dotted), and 600 M (pink dashed 
dotted), vscan = 0.1 V·s
-1. Electrolyte: PBS (0.25 M, pH 7.0) 
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Figure 7. Amperometric responses for AuNPs-GO/Au-IDA electrode to successive 
additions of: A-B) AA at 0.75 V, C-D) UA at 1.0 V in stirred PBS (0.25 M, pH 7.0).  Ei 
= 0.5 V.   
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Figure 8. Calibration curves for AuNPs-GO/Au-IDA modified electrodes towards: A) 
AA additions. Inset: ; B) UA additions. Data corresponding to Figure 7. 
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Figure 9. Cyclic voltammograms of AuNPs-GO/Au-IDA modified electrode for 
successive additions of: A) AA on a solution of UA 600 M (black solid line: 0 M AA 
; green dashed: 30 M AA; blue dotted: 60M AA; pink dashed dotted: 90 M AA; B) 
UA on a solution of AA 275 M (black solid line: 0 M UA; green dashed: 200 M 
UA; blue dotted: 400 M UA; pink dashed dotted: 600 M UA). Electrolyte : PBS 
(0.25 M, pH 7.0) 
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Figure 10. i-t curves obtained for interference study of UA on: A) AA 30 M; B) AA 90 
M . Ei = 0.5 V, Ef = 0.75 V. Electrode used: AuNPs-GO/Au-IDA. Electrolyte: PBS 
(0.25 M, pH 7.0) 
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Figure 11. i-t curves obtained for interference study of AA on: A) UA 120 M; B) UA 
450 M . Ei = 0.5 V, Ef = 1.0 V. Electrode used: AuNPs-GO/Au-IDA. Electrolyte: PBS 
(0.25 M, pH 7.0) 
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Figure 12. i-t curves for interference study of glucose 5 mM, dopamine 1 M and 
epinephrine 0.5 M on: A) AA solution (50 M) at 0.75 V; b) UA solution (420 M) at 
1.0 V. Ei = 0.5 V. Electrode used: AuNPs-GO/Au-IDA. Electrolyte: PBS (0.25 M, pH 
7.0). 
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Figure 13. Inter-sensor reproducibility studied on urine sample by chronoamperometry 
for five electrodes at 0.95 V (black dots) and 1.2 V (red dots). Ei = 0.5 V. Electrode 
used: AuNPs-GO/Au-IDA. Electrolyte: PBS (0.25 M, pH 7.0). 
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Table 1. Analytical figures of merit for the quantification of AA and UA by the AuNPs-
GO/Au-IDA modified electrode.  
 
Parameter 
Analyte 
AA UA 
Sensitivity (nA·mM-1) 830 ± 60 728 ± 16 
Intercept (nA) 7 ± 5 13 ± 7 
r 0.996 0.999 
N 10 12 
n 3 3 
Working range (µM) 4.6-193 2-1000 
LOD (M) 1.4 0.62 
LOQ (µM) 4.6 2 
CV (%) 
(n = 3; 20 M) 
16 13 
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Table 2. Comparison of analytical characteristics for several electrochemical AA, and 
UA sensors. 
 
Detection Limit (M)  Linear Range (M)  Ref. 
AA UA  AA UA   
Mesoporous nitrogen 
rich carbon/GCE 
0.01 0.01 
 
1 - 700 0.01 - 80 
 
[38] 
Cysteine sonogel-
carbon modified 
electrode 
50 10 
 
50-100 10-100 
 
[39] 
[Ni(phen)2]2+-
SWCNTs/GCE 
12 0.76 
 
30-1546 1-1407 
 
[40] 
CNF-CPE 2 0.2 
 
2-64 0.8-16.8 
 
[41] 
Reduced graphene 
oxide/GCE 
300 0.5 
 
500-2000 0.5-60 
 
[42] 
AuRGO/GCE 51 1.8  240-1500 8.8-53  [43] 
Au@Pd-RGO/GCE 0.02 0.005  0.1-1000 0.02-500  [44] 
AuNPs-GO/GCE 200 20  200-800 20-260  [22] 
AuNPs-GO/Au-IDA 1.4 0.62 
 
4.6-193 2-1000 
 This 
work 
 
